Antifungal activity of chromatographic fractions of hexane extract x 1-2 of Eucalyptus torelliana (Corymbia torelliana) on the in vitro growth of candida albicans candida tropicalis and candida glabrata
1 Laboratory of Biology and Health, UFR Biosciences, Félix HOUPHOUET-BOIGNY University, Côte d’Ivoire.
2 National Center of Floristics, Félix HOUPHOUËT-BOIGNY University, Côte d’Ivoire.
Research Article
GSC Biological and Pharmaceutical Sciences, 2022, 20(01), 277–283.
Article DOI: 10.30574/gscbps.2022.20.1.0293
Publication history:
Received on 10 June 2022; revised on 16 July 2022; accepted on 18 July 2022
Abstract:
In developing countries (DC), general mortality is mainly due to infectious diseases which outweigh cardiovascular and degenerative diseases as well as cancers. Among these, opportunistic candidiasis is on the rise among HIV/AIDS patients. AIDS remains the leading cause of death in young adults in developing countries. In view of the growth of infectious diseases, our research team tested the chromatographic fractions of the X1-2 Eucalyptus torelliana extract (ornamental plants) on the in vitro growth of candida albicans, candida tropicalis and candida glabrata. Among these fractions, fraction F5 showed the best activity on the three germs tested with a CMF value of 62.5 µg/mL for each germ.
Keywords:
Chromatography; Infectious diseases; Candidiasis; Eucalyptus torelliana
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
